If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

ATHA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 14.90%

Insider Buying (Last 12 Months): $1,198,630.00

Insider Selling (Last 12 Months): $39,723.23

Athira Pharma Insider Trading History Chart

Athira Pharma Share Price & Price History

^$3.66

▼ -0.05 (-1.35%)

As of 02/6/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Athira Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/28/2022	Glenna Mileson	CFO	Buy	50,000	$2.85	$142,500.00	159,930
12/2/2022	Kelly A Romano	Director	Buy	30,000	$3.29	$98,700.00	38,315
11/15/2022	Hans Moebius	Insider	Buy	5,000	$3.29	$16,450.00	65,836
6/29/2022	Perceptive Advisors Llc	Director	Buy	270,000	$2.99	$807,300.00	3,695,916
6/28/2022	Hans Moebius	Insider	Buy	10,000	$2.88	$28,800.00	52,955
6/23/2022	Mark James Litton	CEO	Sell	7,960	$2.69	$21,412.40	128,555
6/23/2022	Mark Worthington	General Counsel	Sell	2,614	$2.69	$7,031.66	19,097
6/23/2022	Rachel Lenington	COO	Sell	4,193	$2.69	$11,279.17	5,807
3/31/2022	Kelly A Romano	Director	Buy	8,000	$13.11	$104,880.00
1/25/2021	Perceptive Advisors Llc	Director	Buy	311,111	$22.50	$6,999,997.50
9/22/2020	Joseph Edelman	Director	Buy	1,058,824	$17.00	$18,000,008.00

Profit From the Commercial Solar Boom?

From Investing Trends | Ad

Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered.

See What's Going on With the Solar Industry

SEC Filings (Institutional Ownership Changes) for Athira Pharma (NASDAQ:ATHA)

58.67% of Athira Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Athira Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/2/2023	Bailard Inc.	45,094	$0.14M	0.0%	N/A	0.119%
1/25/2023	Lindbrook Capital LLC	11,407	$36K	0.0%	-32.6%	0.030%
1/19/2023	Rothschild Investment Corp IL	31,100	$99K	0.0%	N/A	0.082%
12/8/2022	Bank of New York Mellon Corp	109,796	$0.33M	0.0%	+16.4%	0.290%
11/16/2022	Balyasny Asset Management LLC	12,518	$37K	0.0%	N/A	0.033%
11/16/2022	Jane Street Group LLC	21,027	$63K	0.0%	-68.7%	0.056%
11/15/2022	Alliancebernstein L.P.	76,600	$0.23M	0.0%	+14.5%	0.202%
11/15/2022	State Street Corp	782,154	$2.32M	0.0%	-14.1%	2.068%
11/15/2022	Public Employees Retirement System of Ohio	33,500	$99K	0.0%	N/A	0.089%
11/15/2022	Jacobs Levy Equity Management Inc.	251,935	$0.75M	0.0%	N/A	0.666%
11/15/2022	Algert Global LLC	35,190	$0.11M	0.0%	N/A	0.093%
11/15/2022	Two Sigma Advisers LP	347,400	$1.03M	0.0%	+229.0%	0.918%
11/15/2022	Two Sigma Investments LP	360,643	$1.07M	0.0%	+29.5%	0.953%
11/15/2022	Vanguard Group Inc.	1,832,030	$5.44M	0.0%	+13.7%	4.843%
11/15/2022	Pathstone Family Office LLC	1,815,540	$5.39M	0.1%	+7.5%	4.799%
11/15/2022	Prelude Capital Management LLC	61,222	$0.18M	0.0%	+92.5%	0.162%
11/15/2022	Pura Vida Investments LLC	139,924	$0.42M	0.0%	-47.8%	0.370%
11/15/2022	Bank of New York Mellon Corp	109,796	$0.33M	0.0%	+16.4%	0.290%
11/15/2022	BlackRock Inc.	2,591,089	$7.70M	0.0%	+4.3%	6.849%
11/14/2022	Tudor Investment Corp Et Al	69,770	$0.21M	0.0%	+66.1%	0.184%
11/14/2022	Cubist Systematic Strategies LLC	30,524	$91K	0.0%	-23.8%	0.081%
11/14/2022	Renaissance Technologies LLC	235,003	$0.70M	0.0%	N/A	0.621%
11/10/2022	Dimensional Fund Advisors LP	20,895	$62K	0.0%	-20.8%	0.055%
11/10/2022	Tower Research Capital LLC TRC	17,991	$53K	0.0%	+853.9%	0.048%
11/10/2022	UBS Group AG	65,122	$0.19M	0.0%	+14.6%	0.172%
11/3/2022	Barclays PLC	166,768	$0.50M	0.0%	+185.9%	0.441%
11/2/2022	Rockefeller Capital Management L.P.	30,100	$89K	0.0%	+198.0%	0.080%
10/27/2022	Sargent Investment Group LLC	14,932	$47K	0.0%	+45.3%	0.039%
10/24/2022	Clear Creek Financial Management LLC	10,000	$30K	0.0%	-24.7%	0.026%
8/24/2022	Prelude Capital Management LLC	31,800	$97K	0.0%	+189.1%	0.084%
8/16/2022	First Republic Investment Management Inc.	20,200	$62K	0.0%	N/A	0.054%
8/16/2022	Jane Street Group LLC	67,244	$0.21M	0.0%	-662.8%	0.179%
8/16/2022	Pura Vida Investments LLC	268,131	$0.82M	0.0%	-21.0%	0.712%
8/15/2022	State Street Corp	910,375	$2.78M	0.0%	+10.0%	2.419%
8/15/2022	Cubist Systematic Strategies LLC	40,076	$0.12M	0.0%	+89.1%	0.106%
8/15/2022	Millennium Management LLC	34,308	$0.11M	0.0%	N/A	0.091%
8/12/2022	Northern Trust Corp	280,044	$0.86M	0.0%	+1.3%	0.744%
8/12/2022	Rhumbline Advisers	47,313	$0.14M	0.0%	+17.2%	0.126%
8/8/2022	Simon Quick Advisors LLC	20,538	$78K	0.0%	N/A	0.055%
8/3/2022	Laird Norton Trust Company LLC	120,000	$0.37M	0.0%	+50.0%	0.319%
7/29/2022	SG Americas Securities LLC	12,504	$38K	0.0%	N/A	0.033%
7/26/2022	Sargent Investment Group LLC	10,280	$31K	0.0%	N/A	0.027%
7/25/2022	Bristlecone Advisors LLC	700,926	$2.14M	0.3%	-8.0%	1.862%
7/13/2022	Private Advisor Group LLC	14,475	$44K	0.0%	N/A	0.038%
6/30/2022	Amalgamated Bank	3,899	$53K	0.0%	N/A	0.010%
6/7/2022	Bank of America Corp DE	358,742	$4.84M	0.0%	+50.8%	0.953%
5/27/2022	Walleye Capital LLC	105,723	$1.43M	0.0%	N/A	0.281%
5/17/2022	Walleye Capital LLC	105,723	$1.43M	0.0%	N/A	0.281%
5/17/2022	Royal Bank of Canada	10,617	$0.14M	0.0%	-58.3%	0.028%
5/16/2022	California State Teachers Retirement System	13,881	$0.19M	0.0%	-20.3%	0.037%
5/16/2022	Goldman Sachs Group Inc.	80,341	$1.08M	0.0%	-18.6%	0.214%
5/16/2022	Woodline Partners LP	197,589	$2.67M	0.0%	N/A	0.525%
5/16/2022	Wellington Management Group LLP	115,900	$1.57M	0.0%	+5.1%	0.308%
5/16/2022	State Street Corp	827,574	$11.17M	0.0%	+39.0%	2.200%
5/16/2022	Prelude Capital Management LLC	11,000	$0.15M	0.0%	N/A	0.029%
5/16/2022	Invesco Ltd.	10,168	$0.14M	0.0%	N/A	0.027%
5/16/2022	UBS Group AG	56,315	$0.76M	0.0%	+326.8%	0.150%
5/13/2022	Silverarc Capital Management LLC	10,000	$26.96M	11.2%	N/A	0.027%
5/13/2022	Renaissance Technologies LLC	37,400	$0.51M	0.0%	-67.1%	0.099%
5/13/2022	Northern Trust Corp	276,372	$3.73M	0.0%	-4.3%	0.735%
5/13/2022	Easterly Investment Partners LLC	33,500	$0.45M	0.0%	+21.8%	0.089%
5/13/2022	Wasatch Advisors Inc.	1,274,791	$17.21M	0.1%	+2.6%	3.388%
5/13/2022	Vanguard Group Inc.	1,511,078	$20.40M	0.0%	-1.6%	4.017%
5/13/2022	Dimensional Fund Advisors LP	48,761	$0.66M	0.0%	N/A	0.130%
5/12/2022	BlackRock Inc.	2,415,102	$32.60M	0.0%	-1.7%	6.419%
5/12/2022	Panagora Asset Management Inc.	47,954	$0.65M	0.0%	N/A	0.127%
5/12/2022	Metropolitan Life Insurance Co NY	2,773	$37K	0.0%	-73.1%	0.007%
5/12/2022	MetLife Investment Management LLC	21,230	$0.29M	0.0%	+54.9%	0.056%
5/12/2022	Monashee Investment Management LLC	100,000	$1.35M	0.4%	N/A	0.266%
5/12/2022	Citigroup Inc.	5,387	$73K	0.0%	-48.3%	0.014%
5/11/2022	JPMorgan Chase & Co.	19,500	$0.26M	0.0%	-94.0%	0.052%
4/29/2022	Nisa Investment Advisors LLC	1,936	$26K	0.0%	+720.3%	0.005%
4/25/2022	Tradewinds Capital Management LLC	8,517	$0.12M	0.0%	N/A	0.023%
4/21/2022	Zurcher Kantonalbank Zurich Cantonalbank	2,379	$32K	0.0%	N/A	0.006%
4/21/2022	Lindbrook Capital LLC	24,173	$0.33M	0.1%	+4.1%	0.064%
4/20/2022	Belvedere Trading LLC	51,098	$0.59M	0.0%	-10.8%	0.136%
2/25/2022	AlphaCentric Advisors LLC	20,538	$0.27M	0.1%	N/A	0.055%
2/16/2022	Wasatch Advisors Inc.	1,242,423	$16.19M	0.1%	+38.6%	3.326%
2/14/2022	Virtus ETF Advisers LLC	12,249	$0.16M	0.1%	+11.8%	0.033%
2/14/2022	Point72 Asset Management L.P.	75,000	$0.98M	0.0%	N/A	0.201%
2/14/2022	Journey Strategic Wealth LLC	20,538	$0.27M	0.0%	N/A	0.055%
2/11/2022	Pentwater Capital Management LP	40,000	$0.52M	0.0%	-66.7%	0.107%
2/9/2022	FRG Family Wealth Advisors LLC	10,000	$0.13M	0.0%	N/A	0.027%
2/9/2022	Compagnie Lombard Odier SCmA	2,600	$34K	0.0%	N/A	0.007%
2/8/2022	Easterly Investment Partners LLC	27,500	$0.36M	0.0%	N/A	0.074%
2/8/2022	Bank of America Corp DE	237,866	$3.10M	0.0%	+11.6%	0.637%
2/8/2022	ProShare Advisors LLC	12,302	$0.16M	0.0%	N/A	0.033%
2/7/2022	Laird Norton Trust Company LLC	80,000	$1.04M	0.1%	+700.0%	0.214%
2/7/2022	SG Americas Securities LLC	8,743	$0.11M	0.0%	-54.8%	0.023%
2/7/2022	Potomac Capital Management Inc.	40,000	$0.52M	0.5%	N/A	0.107%
2/3/2022	Advisor Group Holdings Inc.	135,119	$1.76M	0.0%	+3.2%	0.362%
1/25/2022	Belvedere Trading LLC	57,292	$0.57M	0.0%	N/A	0.153%
1/24/2022	Rothschild Investment Corp IL	19,100	$0.25M	0.0%	-12.6%	0.051%
1/18/2022	Lindbrook Capital LLC	23,220	$0.30M	0.0%	+54.5%	0.062%
12/29/2021	Hudson Bay Capital Management LP	200,000	$1.88M	0.0%	+33.3%	0.535%
11/16/2021	Two Sigma Advisers LP	74,900	$0.70M	0.0%	+111.0%	0.201%
11/16/2021	Two Sigma Investments LP	223,201	$2.09M	0.0%	+183.3%	0.598%
11/16/2021	Voloridge Investment Management LLC	114,167	$1.07M	0.0%	N/A	0.306%
11/16/2021	VR Adviser LLC	1,196,196	$11.22M	1.4%	-19.4%	3.207%
11/16/2021	Metropolitan Life Insurance Co NY	7,209	$68K	0.0%	-38.7%	0.019%

Data available starting January 2016

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease. It also develops product candidates, which are in preclinical stage, including ATH-1019 for peripheral nervous system indications; and ATH-1020 for neuropsychiatric conditions. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington.

Today's Range

Now: $3.66

$3.57

$3.75

50 Day Range

MA: $3.40

$2.84

$4.22

52 Week Range

Now: $3.66

$2.53

$14.22

Volume

257,926 shs

Average Volume

448,248 shs

Market Capitalization

$138.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.85

Who are the company insiders with the largest holdings of Athira Pharma?: Athira Pharma's top insider shareholders include:
Perceptive Advisors Llc (Director)
Glenna Mileson (CFO)
Mark James Litton (CEO)
Hans Moebius (Insider)
Kelly A Romano (Director)
Mark Worthington (General Counsel)
Rachel Lenington (COO)
Learn More about top insider investors at Athira Pharma.
Who are the major institutional investors of Athira Pharma?: Athira Pharma's top institutional investors include:
Bailard Inc. — 0.12%
Rothschild Investment Corp IL — 0.08%
Simplex Trading LLC — 0.00%
Lindbrook Capital LLC — 0.03%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Athira Pharma stock.
Which major investors are selling Athira Pharma stock?: During the previous quarter, ATHA stock was sold by these institutional investors:
Lindbrook Capital LLC
Within the last year, company insiders that have sold Athira Pharma company stock include:
Perceptive Advisors Llc (Director)
Glenna Mileson (CFO)
Mark James Litton (CEO)
Learn More investors selling Athira Pharma stock.
Which major investors are buying Athira Pharma stock?: During the last quarter, ATHA stock was acquired by institutional investors including:
Bailard Inc.
Rothschild Investment Corp IL
Simplex Trading LLC
During the previous year, these company insiders have bought Athira Pharma stock:
Perceptive Advisors Llc (Director)
Glenna Mileson (CFO)
Mark James Litton (CEO)
Hans Moebius (Insider)
Learn More investors buying Athira Pharma stock.